Additional Information
Why We’re Suing HHS and CMS to Challenge Illegal Price Controls U.S. Chamber: Biden Administration Rushes to Implement Drug Price Control Scheme, Failing to Examine the Negative Side Effects for SeniorsCase Updates
U.S. Chamber coalition files notice of appeal to Sixth Circuit of dismissal for lack of venue of their challenge to the drug-price-control provisions of the Inflation Reduction Act
October 04, 2024
Jeffrey S. Bucholtz, Christine M. Carletta, Alexander Kazam, and Gregory A. Ruehlmann of King & Spalding LLP, as well as Tami H. Kirby of Porter Wright Morris & Arthur LLP, served as outside counsel.